Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2005 | 1 |
2007 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
When prostate cancer meets bone: control by wnts.
Cancer Lett. 2007 Aug 18;253(2):170-9. doi: 10.1016/j.canlet.2006.12.040. Epub 2007 Apr 25.
Cancer Lett. 2007.
PMID: 17462819
Review.
Osteoprotegerin in prostate cancer bone metastasis.
Corey E, Brown LG, Kiefer JA, Quinn JE, Pitts TE, Blair JM, Vessella RL.
Corey E, et al.
Cancer Res. 2005 Mar 1;65(5):1710-8. doi: 10.1158/0008-5472.CAN-04-2033.
Cancer Res. 2005.
PMID: 15753366
Item in Clipboard
Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases.
Morrissey C, Kostenuik PL, Brown LG, Vessella RL, Corey E.
Morrissey C, et al.
BMC Cancer. 2007 Aug 3;7:148. doi: 10.1186/1471-2407-7-148.
BMC Cancer. 2007.
PMID: 17683568
Free PMC article.
Item in Clipboard
The effect of osteoprotegerin administration on the intra-tibial growth of the osteoblastic LuCaP 23.1 prostate cancer xenograft.
Kiefer JA, Vessella RL, Quinn JE, Odman AM, Zhang J, Keller ET, Kostenuik PJ, Dunstan CR, Corey E.
Kiefer JA, et al.
Clin Exp Metastasis. 2004;21(5):381-7. doi: 10.1007/s10585-004-2869-0.
Clin Exp Metastasis. 2004.
PMID: 15672862
Free article.
Item in Clipboard
Cite
Cite